SMS Terms & Conditions
Parents and Caregivers:
By agreeing to receive marketing messages, you consent to receive text messages on behalf of the Sanofi Health News Program at the mobile telephone number(s) that you provide. Text “STOP”, “SMSSTOP”, “DNPSTOP”, “TEXTOUT”, “DPOUT”, or “DEOUT” to 43601 to opt out at any time. Text “HELP”, “SMSHELP”, “DNPHELP”, “TEXTHELP”, “DPHELP”, or “DEHELP” to 43601 for help at any time. For additional support call 1-855-239-3678. Message and data rates may apply for any messages sent to you from us and to us from you. Messaging frequency varies. If you have any questions about your text plan or data plan, it is best to contact your wireless provider. Participating Carriers include all U.S.-Based Carriers. Messages may be delayed or undelivered for various reasons. Sanofi, Eversana Intouch, carriers, and any service providers utilized by Eversana Intouch to send messages are not liable for delayed or undelivered messages. If you have questions regarding privacy, please read our Privacy Policy.
Healthcare Professionals:
By agreeing to receive marketing messages, you consent to receive text messages on behalf of the Beyfortus (nirsevimab-alip) Alerts Program at the mobile telephone number(s) that you provide. Text “STOP”, “SMSSTOP”, “DNPSTOP”, “TEXTOUT”, “DPOUT”, or “DEOUT” to 91062 to opt out at any time. Text “HELP”, “SMSHELP”, “DNPHELP”, “TEXTHELP”, “DPHELP”, or “DEHELP” to 91062 for help at any time. For additional support call 1-855-239-3678. Message and data rates may apply for any messages sent to you from us and to us from you. Messaging frequency varies. If you have any questions about your text plan or data plan, it is best to contact your wireless provider. Participating Carriers include all U.S.-Based Carriers. Messages may be delayed or undelivered for various reasons. Sanofi, Eversana Intouch, carriers, and any service providers utilized by Eversana Intouch to send messages are not liable for delayed or undelivered messages. If you have questions regarding privacy, please read our Privacy Policy.
Your child should not take Beyfortus if your child has a history of serious allergic reactions to nirsevimab-alip or any of the ingredients in Beyfortus.
Before your child receives Beyfortus, tell your healthcare provider about all of your child’s medical conditions, including if your child:
- has ever had a reaction to Beyfortus.
- has bleeding or bruising problems. If your child has a problem with bleeding or bruises easily, an injection could cause a problem.
Tell your healthcare provider about all the medicines your child takes, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Your infant should not receive a medicine called palivizumab if they have already received Beyfortus in the same RSV season.
Serious allergic reactions have happened with Beyfortus. Get medical help right away if your child has any of the following signs or symptoms of a serious allergic reaction:
- swelling of the face, mouth, or tongue
- difficulty swallowing or breathing
- unresponsiveness
- bluish color of skin, lips, or under fingernails
- muscle weakness
- severe rash, hives, or itching
The most common side effects of Beyfortus include rash and pain, swelling, or hardness at the site of your child’s injection. These are not all the possible side effects of Beyfortus. Call your healthcare provider if you have questions about side effects.
Please see full Prescribing Information, including Patient Information, for more details.
Click here to learn more about Sanofi’s commitment to fighting counterfeit drugs.
Beyfortus is a prescription medicine used to help prevent a serious lung disease caused by Respiratory Syncytial Virus (RSV) in:
- Newborns and babies under 1 year of age born during or entering their first RSV season.
- Children up to 24 months of age who remain at risk of severe RSV disease through their second RSV season.
